Susan Band Horwitz Selected Research

Susan Band Horwitz Research Topics

Disease

32	Neoplasms (Cancer) 01/2020 - 06/2002
11	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 10/2003
11	Carcinoma (Carcinomatosis) 01/2018 - 06/2002
4	Lung Neoplasms (Lung Cancer) 01/2014 - 07/2004
4	Breast Neoplasms (Breast Cancer) 04/2013 - 07/2002
4	Aneuploidy (Aneuploid) 01/2006 - 04/2002
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2007 - 11/2001
2	Neoplasm Metastasis (Metastasis) 01/2014 - 07/2008
2	Carcinogenesis 08/2012 - 07/2008
2	Ovarian Epithelial Carcinoma 11/2010 - 12/2005
1	Residual Neoplasm 04/2013
1	Carcinosarcoma 04/2009
1	Disease Progression 04/2009
1	Liver Neoplasms (Liver Cancer) 07/2008
1	Hematologic Neoplasms (Hematological Malignancy) 06/2008
1	Sarcoma (Soft Tissue Sarcoma) 12/2007
1	Adenocarcinoma 11/2007
1	Substance-Related Disorders (Drug Abuse) 06/2005
1	Tetraploidy 11/2003

Drug/Important Bio-Agent (IBA)

20	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 11/2001
12	TubulinIBA 01/2018 - 07/2002
9	Pharmaceutical PreparationsIBA 11/2016 - 06/2002
6	Excipients (Suspending Agents)IBA 01/2018 - 04/2002
6	discodermolideIBA 01/2018 - 04/2002
6	epothilone B (EPO906)IBA 01/2014 - 04/2002
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 06/2002
4	taxaneIBA 01/2020 - 02/2004
4	ixabepilone (BMS 247550)FDA Link 01/2014 - 07/2002
3	Proteins (Proteins, Gene)FDA Link 06/2010 - 07/2002
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018 - 11/2007
2	Taxoids (Taxanes)IBA 01/2018 - 06/2008
2	Biological ProductsIBA 01/2018 - 09/2011
2	human ERBB2 proteinIBA 04/2013 - 04/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2013 - 01/2011
2	Hormones (Hormone)IBA 04/2013 - 04/2009
2	Biomarkers (Surrogate Marker)IBA 04/2013 - 06/2010
2	Protein Isoforms (Isoforms)IBA 08/2012 - 06/2002
2	2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamideIBA 12/2007 - 04/2005
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2003 - 07/2002
1	ParaffinIBA 01/2018
1	eribulin FDA Link 11/2016
1	Galectin 1 (LGALS1)IBA 01/2014
1	Galectins (Galectin)IBA 01/2014
1	Estrogen ReceptorsIBA 04/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2013
1	A-Form DNA (A-DNA)IBA 01/2011
1	Epithelial Cell Adhesion MoleculeIBA 11/2010
1	AntigensIBA 11/2010
1	Surface Antigens (Surface Antigen)IBA 11/2010
1	Insulin-Like PeptidesIBA 06/2010
1	AntibodiesIBA 06/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2009
1	Somatomedin Receptors (Somatomedin Receptor)IBA 04/2009
1	Growth Factor ReceptorsIBA 04/2009
1	Estrogen Receptor alphaIBA 04/2009
1	Estrogen Receptor betaIBA 04/2009
1	Vinca AlkaloidsIBA 06/2008
1	vinflunineIBA 06/2008
1	ridaforolimusIBA 12/2007
1	Protein Kinases (Protein Kinase)IBA 12/2007
1	Sirolimus (Rapamycin)FDA Link 12/2007
1	TOR Serine-Threonine KinasesIBA 12/2007
1	mirdametinibIBA 12/2007
1	Drug CombinationsIBA 01/2006
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 04/2005
1	U 0126 (UO 126)IBA 04/2005
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 04/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2005
1	Docetaxel (Taxotere)FDA Link 02/2004
1	Indicators and Reagents (Reagents)IBA 11/2003
1	Epothilones (Epothilone)IBA 10/2003
1	multidrug resistance-associated protein 1IBA 07/2002
1	Serine (L-Serine)FDA Link 06/2002
1	Antimitotic AgentsIBA 06/2002
1	NocodazoleIBA 04/2002
1	Vinblastine (Vinblastine Sulfate)FDA Link 04/2002
1	Colchicine FDA LinkGeneric 04/2002
1	Antineoplastic Agents (Antineoplastics)IBA 11/2001

Therapy/Procedure

5	Therapeutics 01/2015 - 01/2006
3	Drug Therapy (Chemotherapy) 01/2020 - 04/2013
1	Salpingectomy 01/2018
1	Neoadjuvant Therapy 04/2013